中医药结合再灌注治疗急性心肌梗死的临床研究进展  

The Clinical Study Development of the Treatment for Acute Myocardial Infarction with Both Traditional Chinese Medicine and Reperfusion Method

作　　者：高伟[1] 刘红旭[1] 周琦[1] 

机构地区：[1]首都医科大学附属北京中医医院,北京100010

出　　处：《中华中医药学刊》2008年第2期326-329,共4页Chinese Archives of Traditional Chinese Medicine

基　　金：首都医学发展科研基金北京医学卫生科技联合攻关项目(2003-I-4)

摘　　要：目的:了解中医药结合再灌注治疗急性心肌梗死的临床研究现状,分析中医药结合再灌注治疗急性心肌梗死的优势及目前存在的问题。方法:①电子检索2000—2005年CNK I中国学术期刊全文数据库中的中医药治疗AM I临床研究文献。②逐一阅读检出文献,筛检出有中医药干预并行再灌注治疗AM I的临床研究文献。③对相关文献进行分类,并进行总结综述。结果:①中医药干预可增加再灌注成功率,降低再灌注损伤,减少再灌注并发证,防止再灌注后再狭窄,并促进侧枝循环的建立。②中医药治疗仍未充分发挥个体化治疗特色,并缺乏大规模、多中心的临床研究的支持。结论:中医药结合再灌注治疗急性心肌梗死取得了一定的临床疗效,应进一步发挥中医药个体化治疗特色,加强循证医学研究。Objective： To summarize the present situation of the treatment for acute myocardial infarction （AMI） with both Traditional Chinese medicine and Reperfusion method, and analyze the advancement and problem with this treatment for AMI. Methods ： （1）The clinical research literatures of TCM treatment for AMI were retrieved from Chinese academic periodical full- text data base. （2）Read the clinical research literatures retrieved from CNKI respectively, and chose those with both treatment of AMI and reperfusion therapy. （3）Classified and summarized the clinical research literatures. Results ： （1）It can increase the achievement ratio of reperfusion, reduce the reperfusion injury and complication, prevent restenosis after reperfusion, and raise the establishment of collateral circulation with the Chinese medicine intervention treatment. （2）The TCM treatment have not educed all of its adventage and characteristic, which needs more supports of large - scale and multi - centre clinical researches. Conclusions ： It had some good effects on the treatment for AMI with both TCM and reperfusion method. We should go on educing the TCM characteristic, and enrichment the evidence - based medicine study.

关 键 词：再灌注治疗 中医药 急性心肌梗死 临床研究 

分 类 号：R259.422.2[医药卫生—中西医结合]